Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue
Chapter 3:Diseases of the blood and blood-forming organs
ICD-10 D76 is a billable code used to indicate a diagnosis of other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue.
ICD-10 code D76 encompasses a variety of conditions characterized by the involvement of lymphoreticular and reticulohistiocytic tissues, which play crucial roles in the immune response and hematopoiesis. This code is often used for diseases that do not fit neatly into other categories but still exhibit significant clinical manifestations related to the lymphatic system, spleen, and immune function. Conditions such as neutropenia, which is a reduction in the number of neutrophils leading to increased susceptibility to infections, may be coded under D76 when associated with lymphoreticular tissue involvement. Other white blood cell disorders, including leukopenia and lymphopenia, may also fall under this code if they are linked to underlying lymphoreticular pathologies. Spleen disorders, such as splenomegaly or hypersplenism, can contribute to the clinical picture, affecting blood cell counts and immune function. Immunodeficiencies, whether primary or secondary, may also be represented under this code when they involve the reticulohistiocytic system, leading to a compromised immune response. Accurate coding requires a thorough understanding of the patient's clinical presentation and the underlying pathophysiology.
Detailed lab results, patient history, and clinical findings related to blood disorders.
Patients presenting with unexplained neutropenia or leukopenia requiring further investigation.
Ensure that all relevant lab tests and their interpretations are documented to support the diagnosis.
Comprehensive immunological assessments and history of infections or autoimmune conditions.
Patients with recurrent infections or autoimmune disorders that may indicate an underlying immunodeficiency.
Document any immunological tests performed and their results to justify the use of D76.
Used to evaluate blood cell counts in patients suspected of having disorders coded under D76.
Document the reason for the CBC and any relevant clinical findings.
Hematologists should ensure that all relevant lab results are included in the patient's record.
Use D76 when the condition involves lymphoreticular and reticulohistiocytic tissue but does not fit into a more specific category. Ensure that documentation supports this coding choice.
